TOWA Pharmaceutical Co (TSE:4553) EV-to-EBIT : 16.18 (As of May. 10, 2024)

View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TOWA Pharmaceutical Co's Enterprise Value is 円299,989 Mil. TOWA Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円18,541 Mil. Therefore, TOWA Pharmaceutical Co's EV-to-EBIT for today is 16.18.

The historical rank and industry rank for TOWA Pharmaceutical Co's EV-to-EBIT or its related term are showing as below:

TSE:4553' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.61 Med: 10.81 Max: 46.66
Current: 16.18

During the past 13 years, the highest EV-to-EBIT of TOWA Pharmaceutical Co was 46.66. The lowest was 6.61. And the median was 10.81.

TSE:4553's EV-to-EBIT is ranked better than
55.75% of 669 companies
in the Drug Manufacturers industry
Industry Median: 17.95 vs TSE:4553: 16.18

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. TOWA Pharmaceutical Co's Enterprise Value for the quarter that ended in Dec. 2023 was 円281,237 Mil. TOWA Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円18,541 Mil. TOWA Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.59%.

TOWA Pharmaceutical Co EV-to-EBIT Historical Data

The historical data trend for TOWA Pharmaceutical Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co EV-to-EBIT Chart

TOWA Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

Get a 7-Day Free Trial

9.39

8.41

9.62

10.97

46.20

TOWA Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															40.03	46.20	23.73	27.06	15.17

Competitive Comparison of TOWA Pharmaceutical Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TOWA Pharmaceutical Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's EV-to-EBIT falls into.

TOWA Pharmaceutical Co EV-to-EBIT Calculation

TOWA Pharmaceutical Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	299989.112	/	18541
	=	16.18

TOWA Pharmaceutical Co's current Enterprise Value is 円299,989 Mil.
TOWA Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円18,541 Mil.

TOWA Pharmaceutical Co (TSE:4553) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

TOWA Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	18541	/	281236.5584
	=	6.59 %

TOWA Pharmaceutical Co's Enterprise Value for the quarter that ended in Dec. 2023 was 円281,237 Mil.
TOWA Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円18,541 Mil.

TOWA Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

TOWA Pharmaceutical Co (TSE:4553) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580

Website

http://www.towayakuhin.co.jp

TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TSE:4553) Headlines

No Headlines